Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Titel:
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Auteur:
Thatcher, Nick Hirsch, Fred R Luft, Alexander V Szczesna, Aleksandra Ciuleanu, Tudor E Dediu, Mircea Ramlau, Rodryg Galiulin, Rinat K Bálint, Beatrix Losonczy, György Kazarnowicz, Andrzej Park, Keunchil Schumann, Christian Reck, Martin Depenbrock, Henrik Nanda, Shivani Kruljac-Letunic, Anamarija Kurek, Raffael Paz-Ares, Luis Socinski, Mark A